Clinical Trial Detail

NCT ID NCT00020566
Title Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma
Recruitment Unknown status
Gender both
Phase Phase III
Variant Requirements No
Sponsors University of Leicester
Indications

Ewing sarcoma

Therapies

Busulfan + Melphalan

Dactinomycin + Doxorubicin + Etoposide + Ifosfamide + Vincristine Sulfate

Age Groups: adult child

No variant requirements are available.